Add to Google

Latest News headlines : WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results - UBM Announces Plans for Japan Pharma & Bio Events - Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project -
  Print

China records 155% increase in heparin sodium exports for Q1

By Cindy Wu, Asia Manufacturing Pharma
Monday, 25 May 2009

During the first quarter of 2009, China exported 30 tons of heparin sodium, up 155 percent year on year, with an average export price of US$4,354 per kilogram, an increase of 100 percent when compared with the same period of 2008, according to the

China Chamber of Commerce for Import & Export of Medicines & Health Products. During 2008, heparin sodium exports from China sharply declined for a while, due to the residual impact of the press coverage over the tainted heparin that had been released into the market. After a period of quality improvement, Chinese heparin sodium active pharmaceutical ingredients (APIs) suppliers have gradually regained
the confidence from foreign importers. The regained confidence was the main driver for the strong export growth in the first quarter.

During the quarter, China exported heparin sodium to 27 countries and regions worldwide, with the US, France, Germany, Austria and Italy the main export destinations. The five countries accounted for 86 percent of China’s overall heparin sodium exports. Export value to Austria and France saw a 206-fold and 54-fold surge, respectively, while those to Belarus, India and Uruguay posted between a six- to seven-fold increase.

Shenzhen Hepalink Bio-Tech, Nanjing King-Friend Biochemical Pharmaceutical, Changzhou

Qianhong Bio-pharma, YanTai Dongcheng Biochemicals and Zhejiang G & F Foreign Trading were the top five Chinese heparin sodium exporters during the first quarter of the year, with their combined exports accounting for 81 percent of the country’s total, demonstrating a significantly increased consolidation within China’s heparin sodium export sector.
Want to read more?

Big changes in the operating environment for China’s aspirin producers
Hainan Haiyao reports strong financial results for Q1 2009
New applications for rapamycin drive market growth in China


WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results
UBM Announces Plans for Japan Pharma & Bio Events
Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project

Lotus Pharmaceuticals Reports Groundbreaking Ceremony
AutekBio, Suma Ventures And Beijing E-Town To Invest In The Largest CMO Project In Asia
NI FlexRIO Product Family Adds PXI Express

Marchesini Group: Working that involves the company at all levels
 

NEW! Send your Press Release for publication - Related Pharmaceutical & Lifesciences websites : Pharmaceutical Manufacturing News | Asia Lifesciences
Pharmaceutical packaging | APIs | Excipients | Generics | Processing | Outsourcing | QA/QC | Pharma Strategy | Drug Discovery | Biotechnology | Clinical Dev.
Subscribe | Unsubscribe | News Archives | Press Release Archives | Advertise | Privacy Statement | Copyright | Contact Publisher

© Intelligent Publishing Media 2009 - All rights reserved.